RARA CRAFT DATABASE for FDA Medical Devices
PMAP160046S010

FDA DEVICE FACTS

VENTANA PD-L1 (SP263) Assay

Ventana Medical Systems, Inc.

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEOctober 15, 2021PRODUCT CODEPLS

Indications for use

VENTANA PD-L1 (SP263) Assay is a qualitative immunohistochemistry assay using rabbit monoclonal anti-PD-L1 clone SP263 intended for use in the assessment of the programmed death ligand-1 (PD-L1) protein in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC) tissue specimens by light microscopy. The VENTANA PD-L1 (SP263) Assay is used with the OptiView DAB IHC Detection Kit for staining on the BenchMark ULTRA instrument. PD-L1 protein expression in NSCLC is determined by the percentage of tumor cells (% TC) with any membrane staining above background.

VENTANA PD-L1 (SP263) assay is indicated as an aid in identifying patients eligible for treatment with the therapy listed in Table 1 for the indication and PD-L1 status in accordance with the approved therapeutic product labeling. Table 1. VENTANA PD-L1 (SP263) Assay Companion Diagnostic Indication Indication for Use PD-L1 Cut-off Therapy NSCLC ≥ 1% TC TECENTRIQ (atezolizumab) Results of the VENTANA PD-L1 (SP263) Assay should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This product is intended for in vitro diagnostic (IVD) use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026